On Tuesday, the Food and Drug Administration recommended that medical providers “pause” administering the Johnson & Johnson Covid-19 vaccine after six women ages 18 to 48 — out of the 6.8 million people who have received the J&J vaccine — were reported to have developed blood clots within two weeks of getting the shot. According to the FDA, one woman died as a result of the clots, and another is in critical condition.
If anything, seeing the FDA act out of an abundance of caution is a sign that systems can work.
This still means that there have been fewer